TCG Completes Active 1st Quarter with Multiple New Assignments and Completed Transactions

Research Triangle Park, NC – Technology Commercialization Group, LLC (TCG), an international firm providing interim management and strategic advisory services to life sciences companies, announced today that it has concluded an active first quarter of 2015, with the hiring of a new partner, five new assignments with international clients, and the successful completion of a worldwide licensing agreement.

Highlights of our new accomplishments during the first quarter 2015 include:

  • The addition of Michael Garrett to the partnership. Mike has over 25 years of business and investment management experience in the life sciences industry
  • Successful completion of a worldwide licensing agreement with an international biopharmaceutical company for a gene therapy platform company
  • Acting as the interim Chief Business Officer for a US biotechnology company specializing in infectious diseases
  • Representing an international biotechnology company to license their oncology program
  • Providing strategic advisory services for a NASDAQ-listed biotechnology company
  • Representing a private European company to partner with US oncology companies
  • Developing a US market entry strategy for a European-based medtech company

If you are considering a strategic transaction or seeking interim management services, TCG’s depth of experience, extensive industry contacts and proven success can help you achieve your goals. Please feel free to contact us directly at our US or European offices:

USA: (919) 941-0700

Europe: +49-6221-27262

You can also learn more about TCG’s capabilities at our new website

About TCG: Founded in 1998, TCG serves life science companies, including medical device, pharmaceutical, and biotechnology companies from its headquarters in the Research Triangle Park region of North Carolina, USA and offices in Heidelberg, Germany. TCG leads and advises transactions, including licensing, strategic partnerships, distribution agreements, asset sales, financings, and acquisitions. TCG also provides interim management, when an experienced executive is needed for a critical project, to enter a new market, to develop a new strategy, or to refocus a company. TCG’s approach is different from other firms in that senior TCG partners, with over 20 years of life science industry experience, lead all assignments.  A global network of industry contacts helps TCG achieve their clients’ objectives rapidly. TCG has successfully completed hundreds of life science projects and assignments.